In one quick announcement Monday, Merck's ($MRK) diabetes drug Januvia became the drug to beat in its class. New study data could boost Januvia's sales by 10% in 2020 ...

WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved expanded labeling for JANUVIA(TM) (sitagliptin), the only DPP-4 inhibitor ...

Januvia comes as a tablet that you swallow. Keep reading for details on Januvia and cost, and how to save money on prescriptions. Note: For more details on Januvia, see this in-depth article. The ...

CHICAGO, June 23 (Reuters) - Merck & Co.'s new diabetes pill, Januvia, improved blood sugar control when added to current therapies, according to data released on Saturday at a major medical meeting.

NEW YORK (Reuters) - Aggressive marketing of Merck & Co.'s new first-in-class diabetes drug Januvia has led to a strong launch, according to data compiled by ImpactRx Inc., a market research company ...